Pro 2012-019 (Jianfeng Group's Announcement on Cancellation of Xinlian Ceramics)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2012-019
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Cancellation of Subsidiary
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Overview of 1. Cancellation of Subsidiaries
Company Company considered the "Proposal on Cancellation of Jinhua Xinlian Ceramics Co., Ltd." at the 7th meeting of the 8th Board of Directors held on October 29, 2012. All 9 directors of the company passed the proposal by written vote. The voting result was: 9 votes in favor, 0 votes against, 0 abstentions.
On October 2, 2010, the 15th meeting of the seventh board of directors of the company made a resolution, deciding that the company's holding subsidiary Jinhua Jianfeng Ceramics Co., Ltd. (hereinafter referred to as: Jianfeng Ceramics) will use the buildings in the factory area of Xiaoshun Town And the land use right to make in-kind capital contributions, the company will use cash to jointly establish a new company to further revitalize the stock assets of Jianfeng ceramics.
On November 17, 2010, the new company was registered and established in Jindong Branch of Jinhua Administration for Industry and Commerce. The company name is Jinhua Xinlian Ceramics Co., Ltd. (hereinafter referred to as Xinlian Ceramics). Xinlian Ceramics is funded in installments. The first phase was funded by the company in cash of 9.7532 million yuan, which was completed in November 2010; the second phase was funded by Jianfeng Ceramics at a price of 22.7568 million yuan after evaluation of the buildings and land use rights of the factory in Xiaoshun Town. However, the asset contribution has not yet been approved by the relevant government departments, and Xinlian Ceramics has not yet conducted business operations. Since this year, Jinhua City has put forward the planning scheme of Jinyi new urban area, and the area where the above-mentioned assets are located for capital contribution is included in the above planning. According to the plan, the ceramic industry is no longer suitable for development in the region. Taking into account the above factors, it was decided to write off Xinlian Ceramics.
2. Xinlian Ceramics Registration
Company Name: Jinhua Xinlian Ceramics Co., Ltd.
Business License Registration Number: 330703000031482
Date of Establishment: November 17, 2011
Registered Capital: 32.51 million yuan
Shareholders: The Company accounts for 30%, peak ceramic accounted for 70%.
Registration Place: filial piety farm
, jindong district, Jinhua City Scope of Business: Production and Sales of Ceramic Products.
3. Xinlian Ceramics Financial Status
As of September 30, 2012, Xinlian Ceramics has a registered capital of 32.51 million yuan, a paid-in capital of 9.7532 million yuan, a total asset of 9.742 million yuan, an owner's equity of 9.742 million yuan, and no fixed assets.
Impact of 4. Cancellation of Xinlian Ceramics on the Company and Other Arrangements Involved
Since Xinlian Ceramics did not actually carry out business and did not have a substantial impact on the Company's operating performance, the cancellation of Xinlian Ceramics will not have a significant impact on the Company's overall business development and profitability.
The board of directors authorized the company's management to organize the liquidation and cancellation of Xinlian Ceramics.
5. Reference Document
1, Resolution of the 15th Board Meeting of the 7th Board of Directors of the Company;
1, Resolution of the 7th Board Meeting of the 8th Board of Directors of the Company.
Board of Directors of Zhejiang Jianfeng Group Co., Ltd.
October 29, 2012
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page